Technology Networks

Archemix Corporation

1 Hampshire Street,
Cambridge,
MA 02139
United States of America
Tel: (617) 621 7700
Fax: (617) 621 9300

Print Email to a friend

Archemix is a drug discovery and development company founded by experts in molecular biology and drug discovery, and backed by experienced biotech investors. Using proprietary technologies, we create biotherapeutics and drug discovery tools.

Further Information: http://www.archemix.com


Related news from our archive

Archemix and Dicerna to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics
Companies combine proprietary aptamer and gene silencing technologies to maximize therapeutic potential of oligonucleotide drug candidates.

Archemix Earns Milestone Payment from Initiation of Phase 1 Clinical Trial by Nuvelo
The milestone payment has been triggered by Nuvelo’s enrollment of the first volunteer in a Phase 1 study of NU172, a thrombin-inhibiting aptamer.

Archemix and Isis Form Strategic Alliance for Aptamer Drug Discovery and Development
The agreement includes a broad intellectual property license agreement and research collaboration covering proprietary chemistries and oligonucleotide-based therapeutics.